FDA outlines faster approval pathway for personalized gene therapies
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
The US Food and Drug Administration published draft guidance on Tuesday to streamline approvals for some individualized gene therapies. Rare disease advocates welcomed the proposal, which could accelerate access to treatments tailored to patients with uncommon genetic mutations.
Continue in the app — vote & join in ➔Source: STAT News · via ahirlevel.hu